Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06784999 · ClinicalTrials.gov registry record · Phase 4
Sufentanil Infusion vs Intravenous Methadone for Postoperative Analgesia Following Head and Neck Dissection With Free Flap or Rotational Reconstruction
A Phase 4 study of Free Flap Reconstruction, sponsored by Indiana University.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 128
- Enrollment target
- 1
- Study location
NCT06784999: Recruiting Phase 4 study of Free Flap Reconstruction, sponsored by Indiana University.
NCT06784999 is a Phase 4 study of Free Flap Reconstruction that is actively recruiting participants, run by Indiana University. The registered enrollment target is 128 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06784999, a Phase 4 study of Free Flap Reconstruction, is actively recruiting participants, sponsored by Indiana University.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 128 participants
- Enrollment target
- 1
- Study location
Study Summary
The main purpose of this study is to determine which type of medication, sufentanil or methadone, is better at controlling pain during and, more importantly, after surgery in patients undergoing a head and neck dissection with free flap or rotational tissue reconstruction. Prior to their operation, subjects will be randomized to receive either Sufentanil or Methadone. After surgery, research staff will obtain information about recovery and pain levels.
Conditions Studied
Interventions
- DRUG sufentanil
- DRUG methadone
Study Locations (1)
Indiana
- Indiana University - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 128 participants |
| Start Date | 2025-01-10 |
| Est. Completion | 2027-11-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06784999
The ClinicalTrials.gov registry entry for NCT06784999 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 128 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (75% lower). The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Free Flap Reconstruction appearing as the primary indexed condition, and to 2 interventions - of which sufentanil is the first listed.
NCT06784999 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT06784999 about?
NCT06784999 is a clinical study titled "Sufentanil Infusion vs Intravenous Methadone for Postoperative Analgesia Following Head and Neck Dissection With Free Flap or Rotational Reconstruction". The main purpose of this study is to determine which type of medication, sufentanil or methadone, is better at controlling pain during and, more importantly, after surgery in patients undergoing a head and neck dissection with free flap or rotational tissue reconstruction. Prior to their operation, ...
What is the current status of trial NCT06784999?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 128 participants. The study started on 2025-01-10. Estimated completion is 2027-11-04.
What conditions does trial NCT06784999 study?
This clinical trial studies the following conditions: Free Flap Reconstruction.
What interventions are being tested in trial NCT06784999?
The interventions under investigation include: sufentanil (DRUG), methadone (DRUG).
Who is sponsoring clinical trial NCT06784999?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06784999 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.